Skedgel, Chris http://orcid.org/0000-0003-4989-8846
Cubi-Molla, Patricia
Mott, David
Gameiro, Sofia
Boivin, Jacky
Al-Janabi, Hareth
Brazier, John
Markert, Marie
Andersson, Fredrik L.
Jofre-Bonet, Mireia
Funding for this research was provided by:
Ferring Pharmaceuticals
Article History
Accepted: 21 February 2023
First Online: 15 March 2023
Declarations
:
: This work was supported by a research grant from Ferring Pharmaceuticals.
: Representatives of the funder provided editorial feedback on interim and final drafts.
: C. Skedgel, P. Cubi-Molla, D. Mott and M. Jofre-Bonet report grants from Ferring Pharmaceuticals in connection with the conduct of the study; and are employees of the Office of Health Economics, a registered charity and Independent Research Organisation, which receives funding from a variety of sources, including the Association of British Pharmaceutical Industries and its members. Marie Markert and Fredrik L. Andersson are employees of Ferring Pharmaceuticals. Sofia Gameiro, Jacky Boivin, Hareth Al-Janabi and John Brazier were compensated for their time on the Project Advisory Group but were not compensated for their contributions to the manuscript. The views and opinions expressed are those of the authors and not necessarily those of their affiliated institutions.